# Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction

> **NCT01244698** · PHASE4 · COMPLETED · sponsor: **Stony Brook University** · enrollment: 132 (actual)

## Conditions studied

- Bacterial Infection
- Anti-infective Agents
- Breast Implantation

## Interventions

- **DRUG:** Cefadroxil discontinued early
- **DRUG:** Cefadroxil until drain removal

## Key facts

- **NCT ID:** NCT01244698
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2014-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01244698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01244698, "Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01244698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*